Goiter, Nodular

甲状腺肿,结节状
  • 文章类型: Journal Article
    本研究旨在探讨桥本甲状腺炎(HT)患者BRAFV600E突变及临床病理改变,甲状腺乳头状癌(PTC)合并桥本甲状腺炎(HT),或结节性甲状腺肿(NG)。共有87例BRAFV600E突变患者被诊断为HT(包括增生性发育不良),带HT的PTC,并注册了带有NG的PTC。临床数据,血清甲状腺功能水平中抗甲状腺球蛋白抗体(TGAb)和甲状腺微粒体抗体(TMAb)的浓度,并对BRAFV600E突变的结果进行回顾性分析.HT和PTC伴HT组的BRAFV600E突变率(P<0.05)与HT和PTC伴NG组的BRAF突变率差异有统计学意义(P<0.05),而HT组的PTC和NG组的PTC之间没有显着差异。TGAb和TMAb升高的HT与基线水平的PTC发生率无差异。HT组的多焦点PTC发生率较高;然而,差异不显著。我们的发现证明BRAF突变可区分良性HT和恶性PTC组。在HT背景下,TGAb和TMAb自身抗体的血清水平与PTC没有直接相关。HT和NG可能同样有助于PTC的发病机理。
    The study aimed to investigate the BRAF V600E mutation and clinicopathological changes among patients with Hashimoto thyroiditis (HT), papillary thyroid carcinoma (PTC) with Hashimoto thyroiditis (HT), or nodular goiter (NG). A total of 87 patients with the BRAF V600E mutation who were diagnosed with HT (including with hyperplasia dysplasia), PTC with HT, and PTC with NG were enrolled. Clinical data, concentrations of antithyroglobulin antibodies (TGAb) and thyroid microsomal antibodies (TMAb) in the serum thyroid-function levels, and the result presence of the BRAF V600E mutation were retrospectively analyzed. There were significant differences in the BRAF V600E mutation rates between the HT and PTC with HT groups ( P <0.05) and the HT and PTC with NG groups ( P <0.05), whereas no significant difference was found between the PTC with HT and PTC with NG groups. There was no difference in incidences of PTC between HT with elevated TGAb and TMAb group and those with baseline levels. The incidence of multifocal PTC was higher in the PTC with HT group; however, the difference was not significant. Our findings documented that BRAF mutation distinguished between the benign HT and the malignant PTC groups. The serum levels of TGAb and TMAb autoantibodies did not directly correlate with PTC in the background of HT. HT and NG may similarly contribute to the pathogenesis of PTC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:甲状腺手术继发的甲状腺组织植入或播散很少见。其中大多数属于甲状腺癌,具有转移潜力,在良性病理中并不常见。
    方法:我们报告了一例31岁女性,在经口内镜甲状腺切除术前庭入路5年后,发现甲状腺组织多次皮下植入。对甲状腺手术继发的甲状腺组织植入进行了全面的文献检索。
    结果:在之前的手术中意外撕裂胶囊可能导致皮下植入。通过文献综述,共纳入29篇文献,共47例患者.33.3%为良性病变,植入主要是继发于细针穿刺活检(46.5%)。
    结论:内镜甲状腺手术后皮下或端口植入可能发生在良性甲状腺病变中,因此,无论其组织病理学性质如何,手术期间都必须严格遵守肿瘤原则。
    Extrathyroid implantation or dissemination of thyroid tissue secondary to a thyroid procedure is rare. Most of these belonged to thyroid carcinoma with metastatic potential and uncommon for benign pathologies.
    We report the case of a 31-year-old female who was identified to have multiple subcutaneous implantation of thyroid tissue 5 years after transoral endoscopic thyroidectomy vestibular approach. A comprehensive literature search on implantation of thyroid tissue secondary to thyroid procedures was performed.
    Accidental tearing of the capsule during previous surgery may lead to the subcutaneous implantation. Through literature review, a total 29 articles with 47 patients were identified. 33.3% were benign lesions, and implantation was mostly secondary to fine needle aspiration biopsy (46.5%).
    Subcutaneous or port site implantation after endoscopic thyroid surgery may occur in benign thyroid pathologies and therefore, oncologic principles must be strictly followed during surgery regardless of its histopathological nature.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:接触半挥发性有机化合物(SVOCs)可能与甲状腺结节风险有关,但缺乏混合SVOCs暴露影响的研究。传统的分析方法不足以处理混合暴露,而机器学习(ML)似乎是填补环境流行病学研究领域空白的好方法。
    目的:采用不同的ML算法探讨混合SVOCs暴露与甲状腺结节的关系。
    方法:进行了年龄和性别匹配的1:1:1病例对照研究,在50例甲状腺乳头状癌(PTC)中测量了96例血清SVOCs,50个结节性甲状腺肿(NG),50个控制不同的ML技术,如随机森林,AdaBoost是根据它们的预测能力选择的,和变量是根据它们在模型中的权重选择的。使用加权分位数和(WQS)回归和贝叶斯核机回归(BKMR)评估SVOCs暴露对甲状腺结节的混合影响。
    结果:96例SVOCs中43例,检出率>80%。ML算法显示与甲状腺结节相关的SVOCs的选择一致。在单化合物模型中,氟代丁基和苯丙菊酯与PTC和NG呈正相关(均P<0.05)。WQS模型表明,暴露于混合SVOCs与PTC和NG的风险增加有关,混合物以甲氰菊酯为主,其次是fluazifop-丁基和propheram。在BKMR模型中,在高暴露水平下,混合物与甲状腺结节风险呈显著正相关,和氟代丁基显示出与PTC和NG相关的积极作用。
    结论:这项研究证实了ML方法在高维复杂数据中进行变量选择的可行性,并表明混合暴露于SVOCs与PTC和NG的风险增加有关。观察到的关联主要是由氟丁基氯和甲氰菊酯驱动的。调查结果值得进一步调查。
    BACKGROUND: Exposure to semi-volatile organic compounds (SVOCs) may link to thyroid nodule risk, but studies of mixed-SVOCs exposure effects are lacking. Traditional analytical methods are inadequate for dealing with mixed exposures, while machine learning (ML) seems to be a good way to fill the gaps in the field of environmental epidemiology research.
    OBJECTIVE: Different ML algorithms were used to explore the relationship between mixed-SVOCs exposure and thyroid nodule.
    METHODS: A 1:1:1 age- and gender-matched case-control study was conducted in which 96 serum SVOCs were measured in 50 papillary thyroid carcinoma (PTC), 50 nodular goiters (NG), and 50 controls. Different ML techniques such as Random Forest, AdaBoost were selected based on their predictive power, and variables were selected based on their weights in the models. Weighted quantile sum (WQS) regression and Bayesian kernel machine regression (BKMR) were used to assess the mixed effects of the SVOCs exposure on thyroid nodule.
    RESULTS: Forty-three of 96 SVOCs with detection rate >80 % were included in the analysis. ML algorithms showed a consistent selection of SVOCs associated with thyroid nodule. Fluazifop-butyl and fenpropathrin are positively associated with PTC and NG in single compound models (all P < 0.05). WQS model shows that exposure to mixed-SVOCs was associated with an increased risk of PTC and NG, with the mixture dominated by fenpropathrin, followed by fluazifop-butyl and propham. In the BKMR model, mixtures showed a significant positive association with thyroid nodule risk at high exposure levels, and fluazifop-butyl showed positive effects associated with PTC and NG.
    CONCLUSIONS: This study confirms the feasibility of ML methods for variable selection in high-dimensional complex data and showed that mixed exposure to SVOCs was associated with increased risk of PTC and NG. The observed association was primarily driven by fluazifop-butyl and fenpropathrin. The findings warranted further investigation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究的目的是探讨影像组学特征与甲状腺结节(TNs)病理性质之间的潜在关联,并提出了一种可解释的基于影像组学的恶性TN风险预测模型。
    方法:在这项回顾性研究中,收集141例TN患者的计算机断层扫描(CT)影像学和病理资料。数据以4:1的比例随机分为训练组(n=112)和验证组(n=29)。通过使用pyradiogomics工具,总共提取了1316个radiomics特征。通过相关性测试去除冗余特征,并使用最小绝对收缩和选择运算符(LASSO)或最小冗余最大相关性标准来选择特征。最后,4种不同的机器学习模型(RF混合功能,SVM混合特征,射频,和LASSO)被建造。使用接收器工作特性曲线评估了4种模型的性能。校正曲线,决策曲线分析,和Shapley加法移植方法用于评估或解释最佳的影像组学机器学习模型。
    结果:最佳影像组学模型(RF混合特征模型)显示出相对较高的区分度,验证队列的受试者工作特征曲线下面积(AUC)为0.87(95%CI,0.70-0.97;P<0.001)。与常用的LASSO模型(AUC,0.78;95%CI,0.60-0.91;P<0.01),验证集中的AUC有显著改善,净重新分类改进,0.79(95%CI,0.13-1.46;P<0.05),和综合歧视改善,0.20(95%CI,0.10-0.30;P<0.001)。
    结论:基于CT的可解释的影像组学模型通过使用单侧全甲状腺的定量影像组学特征,可以很好地预测良性和恶性TNs。此外,结合不同层特征的数据预处理方法取得了良好的实验效果。
    结论:随着TNs检出率的不断提高,放射科医师的诊断负担也是如此.这项研究建立了一种非侵入性的,可解释和准确的机器学习模型,以快速识别在CT中发现的TN的性质。
    OBJECTIVE: The purpose of this study is to inquire about the potential association between radiomics features and the pathological nature of thyroid nodules (TNs), and to propose an interpretable radiomics-based model for predicting the risk of malignant TN.
    METHODS: In this retrospective study, computed tomography (CT) imaging and pathological data from 141 patients with TN were collected. The data were randomly stratified into a training group (n = 112) and a validation group (n = 29) at a ratio of 4:1. A total of 1316 radiomics features were extracted by using the pyradiomics tool. The redundant features were removed through correlation testing, and the least absolute shrinkage and selection operator (LASSO) or the minimum redundancy maximum relevance standard was used to select features. Finally, 4 different machine learning models (RF Hybrid Feature, SVM Hybrid Feature, RF, and LASSO) were constructed. The performance of the 4 models was evaluated using the receiver operating characteristic curve. The calibration curve, decision curve analysis, and SHapley Additive exPlanations method were used to evaluate or explain the best radiomics machine learning model.
    RESULTS: The optimal radiomics model (RF Hybrid Feature model) demonstrated a relatively high degree of discrimination with an area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI, 0.70-0.97; P < 0.001) for the validation cohort. Compared with the commonly used LASSO model (AUC, 0.78; 95% CI, 0.60-0.91; P < 0.01), there is a significant improvement in AUC in the validation set, net reclassification improvement, 0.79 (95% CI, 0.13-1.46; P < 0.05), and integrated discrimination improvement, 0. 20 (95% CI, 0.10-0.30; P < 0.001).
    CONCLUSIONS: The interpretable radiomics model based on CT performs well in predicting benign and malignant TNs by using quantitative radiomics features of the unilateral total thyroid. In addition, the data preprocessing method incorporating different layers of features has achieved excellent experimental results.
    CONCLUSIONS: As the detection rate of TNs continues to increase, so does the diagnostic burden on radiologists. This study establishes a noninvasive, interpretable and accurate machine learning model to rapidly identify the nature of TN found in CT.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:联合甲状腺细针穿刺(FNA)细胞学检查和B-Raf原癌基因密码子600处的缬氨酸至谷氨酸替换,丝氨酸/苏氨酸激酶(BRAFV600E)突变检测是许多中国大专院校诊断甲状腺结节的方法。我们机构的这项回顾性研究旨在探讨联合方法诊断甲状腺结节的有效性和挑战,以及BRAFV600E突变状态与甲状腺乳头状癌行为之间的相关性。
    方法:回顾了2020年11月至2022年7月甲状腺FNA细胞学和BRAFV600E突变检测结果。共有623名患者,每个人都接受了甲状腺切除术和FNA细胞学诊断后的最终病理检查,包括在研究中。采用χ2检验分析BRAFV600E突变状态与病理参数之间的关系。还根据最终病理评估了单独的FNA细胞学和联合手术的有效性和挑战。
    结果:在623名患者中,591例诊断为甲状腺乳头状癌(PTC),其中456例BRAFV600E突变阳性。它证明了鉴定PTC的近乎完美的特异性,其发病率呈倒U型分布的年龄曲线。最终病理检查显示,联合手术在区分PTC与其他病变方面的敏感性(83.91%)高于单独的FNA细胞学检查(63.45%)(P<0.001)。突变状态与较大的最大肿瘤直径(P=0.003)和包膜浸润趋势(P=0.0542)有关,但可能与中央区淋巴结转移无关(P=0.1846)。结节性甲状腺肿占最初指定为BethesdaIII至V类的大多数良性实体。
    结论:BRAFV600E突变分析补充了细胞病理学,并提高了FNA细胞学样本中PTC的检出率,这是由于突变在中国的患病率很高。BRAFV600E突变未显示与肿瘤侵袭性的统计学相关性。形态学缺陷如组织细胞聚集,结节性甲状腺肿的囊膜细胞,和桥本甲状腺炎的肿瘤细胞,绝大多数在BRAFV600E阴性标本中发现。
    BACKGROUND: Combined thyroid fine-needle aspiration (FNA) cytology and valine-to-glutamate substitution at codon 600 of B-Raf proto-oncogene, serine/threonine kinase (BRAF V600E) mutation detection are procedures used for diagnosing thyroid nodules in many Chinese tertiary institutions. This retrospective study at our institution aimed to explore the effectiveness and challenges of the combined approach in diagnosing thyroid nodules and the correlation between BRAF V600E mutation status and behavior of papillary thyroid carcinoma.
    METHODS: Thyroid FNA cytology and BRAF V600E mutation detection results were reviewed between November 2020 and July 2022. A total of 623 patients, each of whom underwent thyroidectomy and final pathological examination after FNA cytology diagnosis, were included in the study. The relationship between the BRAF V600E mutational status and pathological parameters was analyzed using the χ2 test. The effectiveness and challenges of FNA cytology alone and the combined procedure were also evaluated based on the final pathology.
    RESULTS: Of 623 patients, 591 were diagnosed with papillary thyroid carcinoma (PTC), of which 456 were positive for the BRAF V600E mutation. It demonstrated near-perfect specificity for identifying PTC, and its incidence rate showed an age-specific curve with an inverted U-shaped distribution. The final pathological examination showed that the combined procedure had a higher sensitivity (83.91%) than FNA cytology alone (63.45%) for distinguishing PTC from other lesions (p < 0.001). Mutational status was associated with a larger maximum tumor diameter (p = 0.003) and a tendency of capsular invasion (p = 0.0542) but possibly unrelated to central lymph node metastasis (p = 0.1846). Nodular goiters accounted for most benign entities initially designated as Bethesda categories III-V.
    CONCLUSIONS: BRAF V600E mutational analysis complements cytopathology and improves the PTC detection rate in FNA cytology samples due to the high prevalence of the mutation in China. BRAF V600E mutation does not show a statistical correlation with tumor aggressiveness. Morphological pitfalls such as histocyte aggregation, cystic-lining cells in nodular goiters, and oncocytes in Hashimoto\'s thyroiditis, were overwhelmingly found in BRAF V600E-negative specimens.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:本研究通过分析基于多个数据库的Pendred综合征(PDS)患者甲状腺表型的临床特点,为开展与甲状腺表型相关的随访提供统计数据支持,为随访持续时间和项目选择提供参考。
    方法:通过耳聋变异数据库(DVD)搜索与PDS相关的致病性或可能/致病性突变,ClinVar,和PubMed数据库,对突变位点进行计数,并对特征和甲状腺表型进行分析.
    结果:在多个数据库中报告的PDS病例中,听力表型发作的中位年龄为1.0(1.0,2.0)岁,甲状腺表型发病的中位年龄为14.5(5.8,21.0)岁,甲状腺表型比听力表型延迟的中位年龄为10.0(4.0,17.0)岁.两种表型的发病时间分布存在显著差异(Z=-4.560,p<0.01)。在这些患者中,甲状腺肿的阳性率,甲状腺结节,甲状腺功能异常,高氯酸盐排放试验(PDT)为78%,78%,69%,78%,分别。此外,有移码突变的基因型组甲状腺表型阳性项目数未显著高于无移码突变组(Z=-1.452,p=0.147).
    结论:PDS早期漏诊可能是由于甲状腺表型发病晚,检查项目阳性率非100%所致。因此,甲状腺进入成年期的多项目随访将使患者受益。目前,基因型和表型之间的关系尚不清楚,根据基因型无法确定预后。
    This study aimed to provide statistical data support for the development of thyroid phenotype-related follow-up and reference for follow-up duration and project selection by analyzing the clinical characteristics of thyroid phenotype in Pendred syndrome (PDS) based on multiple databases.
    PDS-related pathogenic or possibly/pathogenic mutations were searched by Deafness Variation Database (DVD), ClinVar, and PubMed databases, the mutation sites were counted and the characteristics and thyroid phenotypes were analyzed.
    The median age of hearing phenotype onset in PDS cases reported in multiple databases was 1.0 (1.0, 2.0) years, the median age of thyroid phenotype onset was 14.5 (5.8, 21.0) years, and the median age that thyroid phenotype was more delayed than hearing phenotype was 10.0 (4.0, 17.0) years. There were significant differences in the distribution of onset time between the two phenotypes (Z=-4.560, p<0.01). In these patients, the positive rates of goiter, thyroid nodules, abnormal thyroid function, and perchlorate discharge test (PDT) were 78%, 78%, 69%, and 78%, respectively. Moreover, the number of thyroid phenotype-positive items in the genotype group with frameshift mutation was not significantly higher than that in the group without frameshift mutation (Z=-1.452, p=0.147).
    The early missed diagnosis of PDS may be due to the late onset of thyroid phenotype and the non-100% positive rate of examination items. Therefore, multi-item follow-up of the thyroid gland into adulthood will benefit patients. At present, the relationship between genotype and phenotype is still unclear, and prognosis cannot be determined according to genotype.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    Pendrin(SLC26A4)是在所选上皮的顶膜中表达的阴离子交换剂。Pendrin消融导致Pendred综合征,与感觉神经性听力损失相关的遗传性疾病,甲状腺机能减退性甲状腺肿,和降低血压。然而,它的分子结构仍然未知,限制了我们对运输结构基础的理解。这里,我们确定了具有对称和不对称同型二聚体构象的小鼠pendrin的低温电子显微镜结构。非对称同源二聚体由一个朝内的原聚体和另一个朝外的原聚体组成,代表同时摄取和分泌-pendrin作为电中性交换器的独特状态。此处呈现的多种构象为阴离子交换提供了反向交替进入机制。这里提供的结构和功能数据揭示了阴离子交换裂缝的特性,并有助于理解疾病相关变异的重要性。这将揭示pendrin交换机制。
    Pendrin (SLC26A4) is an anion exchanger expressed in the apical membranes of selected epithelia. Pendrin ablation causes Pendred syndrome, a genetic disorder associated with sensorineural hearing loss, hypothyroid goiter, and reduced blood pressure. However its molecular structure has remained unknown, limiting our understanding of the structural basis of transport. Here, we determine the cryo-electron microscopy structures of mouse pendrin with symmetric and asymmetric homodimer conformations. The asymmetric homodimer consists of one inward-facing protomer and the other outward-facing protomer, representing coincident uptake and secretion- a unique state of pendrin as an electroneutral exchanger. The multiple conformations presented here provide an inverted alternate-access mechanism for anion exchange. The structural and functional data presented here disclose the properties of an anion exchange cleft and help understand the importance of disease-associated variants, which will shed light on the pendrin exchange mechanism.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:自从发现异位甲状腺以来,肺内异位甲状腺极为罕见。在全世界的文献中只报道了8例。我们介绍了一个10岁女孩的多个肺内异位甲状腺伴结节性甲状腺肿的病例。
    方法:女孩在治疗结节性甲状腺肿时发现双肺多发肺内结节。最初认为肺内病变是转移癌的高可能性。进行了计算机断层扫描引导的经皮肺活检,病理检查证实诊断为异位肺内甲状腺。
    结论:结节性甲状腺肿患儿出现肺部可疑转移时,应考虑肺内甲状腺异位。
    The intrapulmonary ectopic thyroid gland is exceedingly rare since the ectopic thyroid was discovered. Only eight cases have been reported in the worldwide literature. We present a case of multiple intrapulmonary ectopic thyroid glands with nodular goiter in a 10-year-old girl.
    The girl was found with multiple intrapulmonary nodules in bilateral lungs during the treatment of nodular goiter. The intrapulmonary lesions were initially thought to be a high possibility of metastatic cancer. A computed tomography-guided percutaneous lung biopsy was performed, and the pathological examination confirmed that the diagnosis was ectopic intrapulmonary thyroid.
    The ectopic intrapulmonary thyroid should be considered when children with nodular goiter presenting with suspected metastases in the lung.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    甲状旁腺激素(PTH)的异位分泌是恶性肿瘤患者高钙血症的罕见原因。一名56岁的女性,危及生命的高钙血症是由低分化子宫内膜癌分泌PTH并伴随结节性甲状腺肿模拟甲状旁腺肿瘤引起的。细胞减灭术(CRS)后,PTH和钙的升高水平立即降低。病理证实错配修复(MMR)缺陷型子宫内膜癌伴PTH表达。患者在CRS后接受了4个疗程的化疗和1个疗程的免疫治疗。疾病进展导致CRS后约5个月的多器官衰竭和死亡。据我们所知,这是第一例由MMR缺陷型子宫内膜癌伴异位PTH分泌引起的高钙血症,也是首例恶性肿瘤相关性高钙血症并发结节性甲状腺肿的报告.
    Ectopic secretion of parathyroid hormone (PTH) is a rare cause of hypercalcemia in malignancy patients. A 56-year-old woman with life-threatening hypercalcemia was caused by poorly-differentiated endometrial carcinoma secreting PTH with concomitant nodular goiter mimic parathyroid tumors. The elevated level of PTH and calcium decreased immediately after cytoreductive surgery (CRS). The pathology confirmed mismatch repair (MMR)-deficient endometrial carcinoma with PTH expression. The patient received four-course chemotherapy and one-course immunotherapy after CRS. The disease progression led to multiple organ failure and death about five months after CRS. To our knowledge, this is the first case of hypercalcemia caused by MMR-deficient endometrial carcinoma with ectopic PTH secreting and the first report of malignancy associated hypercalcemia complicated with nodular goiter.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:结节性甲状腺肿是一种常见的临床问题,有阻塞性症状的患者首选甲状腺切除术。甲状腺切除术是一项复杂的手术,有一些常见的并发症。三维(3D)计算机断层扫描(CT)重建和3D打印提供可视化的3D解剖结构,在具有最佳疗效和最小并发症的精确手术中具有巨大的价值。这里,我们的目标是在这项技术的指导下进行精确的甲状腺切除术。
    方法:患者是一名80岁女性,患有10年甲状腺肿,1年的呼吸困难,62年前有甲状腺手术史.除了超声检查,获得CT图像以构建3D模型,以识别病变与相邻结构之间的3D关系,使用3D打印机创建和打印气管的3D模型。
    结果:3D模型清楚地呈现了两个叶和峡部的扩散扩大以及甲状腺肿的压缩。在3D指导下,右叶和峡部的手术切除标本为12'7'5厘米,而左叶标本为12'9'6厘米。结节性甲状腺肿和淋巴细胞性甲状腺炎经术后病理证实。除非永久性低钙血症和甲状旁腺功能减退外,甲状腺全切除术后无并发症。
    结论:我们的结果证明,巨大甲状腺肿的全甲状腺切除术具有挑战性,3D图像引导甲状腺切除术有助于精确和安全的切除,并发症少。3DCT重建和3D打印可以提供解剖细节,可以在巨大甲状腺肿患者的甲状腺切除术计划中考虑。
    BACKGROUND: Nodular goiter is a common clinical problem, and thyroidectomy is preferred in patients with obstructive symptoms. Thyroidectomy is a complex procedure with some common complications. Three-dimensional (3D) computed tomography (CT) reconstruction and 3D printing provide visualized 3D anatomical structure, posing an enormously valuable potential in precise surgery with optimal efficacy and minimum complications. Here, we aimed to perform a precise thyroidectomy guided by this technology.
    METHODS: The patient was an 80-year-old woman with 10 years of goiter, 1 year of labored dyspnea, and a history of thyroid surgery 62 years ago. In addition to ultrasonography examination, CT images were obtained to construct the 3D model to identify the 3D relationship between the lesion and adjacent structures, and a 3D model of the trachea was created and printed using a 3D printer.
    RESULTS: The 3D model clearly presented the diffuse enlargement of the two lobes and isthmus and the compression of the goiter. Under the 3D guidance, the operative resection specimen of the right lobe and isthmus was 12 ´ 7 ´ 5 cm, whereas the left lobe specimen was 12 ´ 9 ´ 6 cm. Nodular goiter and lymphocytic thyroiditis were confirmed by postoperative histopathology. There were no complications after total thyroidectomy except for non-permanent hypocalcemia and hypoparathyroidism.
    CONCLUSIONS: Our results proved that total thyroidectomy for giant goiter is challenging, and 3D image-guided thyroidectomy facilitates precise and safe resection with fewer complications. 3D CT reconstruction and 3D printing can provide anatomical details and may be considered in thyroidectomy planning for patients with giant goiter.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号